Review Papers Claim by Claim

 Quick Explanation Copied

 Long Explanation

Key Findings

In severe asthma, women had more IL-17A⁺ CCR6⁺ memory TH17 cells than men (n=14 vs 15; P<.05, Mann-Whitney), while IL-17A/IL-4 dual producers and IL-4⁺ cells did not differ — pointing to a TH17-specific, not TH2-driven, sex difference [citation doi="10.1016/j.jaci.2015.05.046" title="Estrogen and progesterone decrease let-7f microRNA expression and increase IL-23/IL-23 receptor signaling and IL-17A production in patients with severe asthma [2015]" research-extract="Women with severe asthma had increased percentages and total numbers of IL-17A+ CCR6+ memory TH17 cells versus men; dual IL-17A/IL-4 producers, IL-4+ cells, total IgE, BMI, and lung function were similar between sexes." url="https://doi.org/10.1016/j.jaci.2015.05.046" descriptive-anchor-text="Newcomb et al. severe asthma sex dimorphism study" evidence-strength="moderate"]. Mechanistically, TH17-differentiated cells from healthy women showed elevated IL-23R surface expression and reduced let-7f microRNA versus men; a let-7f inhibitor raised IL23R mRNA and IL-17A in both sexes, confirming let-7f's negative regulation [citation doi="10.1016/j.jaci.2015.05.046" title="Newcomb et al. 2015 [2015]" research-extract="TH17 cells from women showed higher IL-23R geometric MFI (1537.6 ± 297.3 vs 602.7 ± 181.5 in men, n=8 vs 7) and decreased let-7f; transfection of a let-7f inhibitor increased IL23R mRNA and IL-17A production." url="https://doi.org/10.1016/j.jaci.2015.05.046" descriptive-anchor-text="IL-23R MFI and let-7f inhibitor data" evidence-strength="moderate"]. In ovariectomized mice, only combined E2+P4 pellets (not either hormone alone or DHT) increased IL-17A and il23r mRNA, recapitulating sham-operated females; adoptive transfer of female D011.10 TH17 cells drove more CXCL1 and BAL neutrophils in OVA-challenged recipients [citation doi="10.1016/j.jaci.2015.05.046" title="Newcomb et al. 2015 [2015]" research-extract="Ovariectomized mice given E2+P4 pellets for 21 days had increased IL-17A and il23r mRNA versus vehicle; female-derived OVA-specific TH17 cells produced ~4484 pg/mL IL-17A vs 2377 pg/mL from male cells and increased neutrophil infiltration." url="https://doi.org/10.1016/j.jaci.2015.05.046" descriptive-anchor-text="E2+P4 mouse data" evidence-strength="moderate"].

Novelty & Broader Context

The paper is the first to connect sex hormones → let-7f → IL-23R → IL-17A in human TH17 cells, building on prior findings that let-7f regulates IL23R in CD4⁺ T cells [citation doi="10.1016/j.jaci.2015.05.046" title="IL-23 receptor regulation by Let-7f in human CD4+ memory T cells [2011]" research-extract="Li et al. showed let-7f miRNA negatively regulates IL-23 receptor expression in human CD4+ memory T cells, providing the mechanistic precedent for the current study." url="https://pubmed.ncbi.nlm.nih.gov/21474389/" descriptive-anchor-text="Li et al. let-7f/IL23R regulation" evidence-strength="moderate"] and that estrogen suppresses let-7f in MCF-7 cells [citation doi="10.1016/j.jaci.2015.05.046" title="Estradiol-regulated microRNAs control estradiol response in breast cancer cells [2009]" research-extract="Bhat-Nakshatri et al. demonstrated that estradiol signaling in MCF-7 breast cancer cells decreases let-7f expression, suggesting estrogen control of this miRNA." url="https://pubmed.ncbi.nlm.nih.gov/19494352/" descriptive-anchor-text="Estradiol-regulated let-7f in MCF-7" evidence-strength="moderate"]. Notably, E2+P4 raised IL-17A but not IL-17F, implying differential regulation of the adjacent Il17a/Il17f genes — potentially epigenetic. This parallels IL-23/IL-17 axis activation in other female-predominant autoimmune diseases where TLR2/IL-6/STAT3/NF-κB drives IL-23/IL-17 [citation doi="10.1186/ar3780" title="TLR2 ligation induces the production of IL-23/IL-17 via IL-6, STAT3 and NF-kB pathway in patients with primary Sjogren's syndrome [2012]" research-extract="Kim et al. showed TLR2 ligation increases IL-23 and IL-17 via IL-6, STAT3, and NF-κB in Sjogren's syndrome PBMCs, an IL-23/IL-17 axis active in another female-predominant autoimmune disease." url="https://doi.org/10.1186/ar3780" descriptive-anchor-text="TLR2-driven IL-23/IL-17 in Sjogren's" evidence-strength="moderate"].

Critical Limitations & Blind Spots

Skeptical appraisal: (1) Neither circulating E2 nor P4 correlated with IL-17A, and acute E2 in vitro had no effect — the authors infer long-term developmental programming, but this is untested directly. (2) In ovariectomized mice, let-7f was NOT significantly lower with E2+P4 vs vehicle, so let-7f cannot fully explain the IL-23R/IL-17A increase — other regulators (SGK1/FOXO1 tested, no differences) remain unidentified. (3) Human cohorts are small (n=7–15/group) and from a single center; no age-at-puberty or menstrual-cycle-phase stratification beyond exclusion criteria. (4) Mouse findings used only female recipients for adoptive transfer, confounding donor sex with recipient milieu. (5) Conflicts of interest exist (Kolls: Boehringer Ingelheim consulting, MiniVax stock), though funder-driven bias in this mechanistic work is unlikely. (6) The therapeutic implication — women may respond better to IL-17 blockade — is speculative; the brodalumab asthma trial did not enrich for IL-17A-high patients [citation doi="10.1016/j.jaci.2015.05.046" title="Randomized, double-blind, placebo-controlled study of brodalumab in moderate to severe asthma [2013]" research-extract="Busse et al. reported brodalumab had little effect on asthma symptoms in unselected moderate-to-severe asthma, underscoring the need for IL-17A-high phenotype enrichment." url="https://pubmed.ncbi.nlm.nih.gov/24120342/" descriptive-anchor-text="Brodalumab asthma trial" evidence-strength="moderate"]. What would falsify the mechanism: showing let-7f/IL23R manipulation in vivo fails to alter IL-17A in a female-specific way, or replicating E2+P4 effects with sex-matched recipient controls.

Bottom line: A rigorous, multi-model (human TH17 + ovariectomized mouse + adoptive transfer) study with moderate evidence strength; the let-7f→IL-23R link is well-supported, but the full hormonal mechanism upstream remains incompletely resolved.

Meta-analysis: Sex Hormones & TH17Design let-7f Causality ExperimentCreate Comparison Graphs

Author Review: Dawn C. NewcombAuthor Review: R. Stokes Peebles JrAuthor Review: Jay K. Kolls

 BGPT Paper Review

Study Novelty

First demonstration linking sex hormones to let-7f-dependent IL-23R/IL-17A regulation in human TH17 cells, though the individual components (let-7f/IL23R, estrogen/let-7f) were previously known; the integrated pathway is new.

Scientific Quality

Strong multi-model design with appropriate nonparametric statistics and honest reporting of negative results (no E2/P4 correlation, let-7f alone insufficient). Weaknesses: small single-center human cohorts, female-only adoptive transfer recipients, and unverified long-term programming hypothesis.

Study Generality

Directly relevant to severe asthma sex dimorphism and conceptually extends to female-predominant TH17-driven diseases (MS, SLE, psoriasis), but the mechanism is tissue/disease-context specific and not tested beyond asthma models.

Study Usefulness

Provides a mechanistic rationale for sex-stratified IL-17/IL-23-targeted therapies in severe asthma and identifies let-7f as a therapeutic node; clinical translation remains unproven.

Study Reproducibility

Detailed methods (reagents, doses, primers, statistical tests) support replication, but no raw data sharing and small per-group ns make exact reproduction vulnerable to donor variability.

Explanatory Depth

Mechanistic chain (hormones → let-7f ↓ → IL-23R ↑ → IL-17A ↑) is supported by inhibitor and ovariectomy experiments, yet the upstream hormone→let-7f transcriptional mechanism and let-7f-independent IL-23R regulators remain undefined — acknowledged by authors.